On November 14, 2016, upon the recommendation of the Nominating and Governance Committee of Neurotrope, Inc.'s board of directors, the board appointed Bruce T. Bernstein as a member of the board, effective immediately, to hold office until the next annual meeting of the stockholders of the company, until his successor is duly elected and qualified, or until his resignation or removal. Effective November 14, 2016, Mr. Bernstein was appointed to serve as the chairman of the audit committee of the board.